‘Attractive’ Option in Recurrent NSCLC
, 2025-05-14 12:57:00 TOPLINE: In patients with recurrent non–small cell lung cancer (NSCLC), salvage thoracic reirradiation prolonged overall survival and progression-free survival. Consolidative immunotherapy following reirradiation further improved overall survival, locoregional control, and freedom from distant metastasis. METHODOLOGY: Many patients with unresectable locally advanced NSCLC who receive definitive chemoradiation experience intrathoracic locoregional failures or recurrences….